Tuning the Aggregation of Plasmonic Probes to Shed Light on Diagnostic Strategies., PMID:40504768
Attenuation of IFITM proteins' antiviral activity through sequestration into intraluminal vesicles of late endosomes., PMID:40501618
IL16 Promotes Plasma Cell Differentiation., PMID:40495388
Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype., PMID:40494885
Comparison of whole blood on filter strips with serum for avian influenza virus antibody detection in wild birds., PMID:40491934
Morphology-dependent entry kinetics and spread of influenza A virus., PMID:40490555
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024)., PMID:40474813
Quantifying the zoonotic risk profile of European influenza A viruses in swine from 2010 to 2020 inclusive., PMID:40464577
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019-2020 Season in Philadelphia, Pennsylvania., PMID:40452165
Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus., PMID:40452158
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024., PMID:40439507
Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus., PMID:40435634
Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan., PMID:40431637
Dynamic Interaction Between SARS-CoV-2 and Influenza A Virus Infection in Human Respiratory Tissues and Cells., PMID:40431161
Acute Respiratory and Influenza Viruses Circulating in Kazakhstan During 2018-2024., PMID:40430813
Evidence Suggesting Possible Exposure to Influenza A Virus in Neotropical Bats from Mexico., PMID:40430735
Virus-specific antibody responses in multiple sclerosis patients treated with Ocrevus., PMID:40398376
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo., PMID:40398322
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface., PMID:40391889
Development of Novel Multiplex Detection Platforms Based on Multiepitope Nanobody Pairs for Rapid Screening of Waterborne Pathogens., PMID:40377907
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma., PMID:40372494
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Maternal vaccination partially protects piglets against influenza A virus associated alteration of the microbiome and hippocampal gene expression., PMID:40359780
Case Report: The effect of asplenia on the response to influenza vaccination and passive transfer of immunity in an adult female pig., PMID:40356897
Kinetic MUNANA assay reveals functionally relevant antibody epitopes on Influenza A virus neuraminidase., PMID:40348878
Identification & genetic & virological characterisation of a human case of avian influenza A (H9N2) virus from Eastern India., PMID:40347502
Recombinant Salmonella vector delivery 3M2e-ferritin fusion nanoparticles provide cross protection against H9N2 and H7N9 avian influenza viruses., PMID:40339259
Evaluating Bacillus Calmette-Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice., PMID:40338109
Interferon-β treatment reverses the detrimental effect of B-cell depletion therapy on respiratory virus infection., PMID:40334083
M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy., PMID:40333315
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection., PMID:40333263
Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial., PMID:40332892
Pre-Existing Allergic Inflammation Alters Both Innate and Adaptive Immune Responses in Mice Co-Infected with Influenza Virus., PMID:40331962
Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine., PMID:40328185
Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation., PMID:40321807
Intranasally administered whole virion inactivated vaccine against clade 2.3.4.4b H5N1 influenza virus with optimized antigen and increased cross-protection., PMID:40320528
Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection., PMID:40319941
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models., PMID:40312392
Genome-scale evolution and phylodynamics of swine influenza A viruses in China: a genomic epidemiology study., PMID:40311646
Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023-2024 flu season., PMID:40307541
Severe Avian Influenza A H5N1 Clade 2.3.4.4b Virus Infection in a Human with Continuation of SARS-CoV-2 Viral RNAs., PMID:40303095
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses., PMID:40301359
Epitope-optimized vaccine elicits enduring immunity against swine influenza A virus., PMID:40301303
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype., PMID:40284987
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies., PMID:40267182
Application of Humanized MHC Transgenic Mice in the Screening of HLA-Restricted T Cell Epitopes for Influenza Vaccines., PMID:40266241
For research use only. Not for human or drug use.
